CNR1 anticorps (Internal Region)

N° du produit ABIN374611

Cet anticorps Chèvre Polyclonal détecte spécifiquement CNR1 dans WB. Il présente une réactivité envers Humain, Rat, Souris, Chien et Cat.

Aperçu rapide pour CNR1 anticorps (Internal Region) (ABIN374611)

Antigène: CNR1 (Cannabinoid Receptor 1 (CNR1))

Reactivité: Humain, Rat, Souris, Chien, Cat

Hôte: Chèvre

Clonalité: Polyclonal

Conjugué: Cet anticorp CNR1 est non-conjugé

Application: Western Blotting (WB)

Détail du produit anti-CNR1 anticorps

Épitope: Internal Region

Specificité: This antibody reacts to Cannabinoid receptor 1.

Réactivité croisée (Details): Species reactivity (expected):Rat, Canine.
Species reactivity (tested):Human, Mouse.

Purification: Affinity chromatography

Immunogène: Peptide with sequence C-HTSEDGKVQVTRPDQ, from the internal region of the protein sequence

Information d'application

Indications d'application: Peptide ELISA: 1/32000. Western Blot: 0.1 - 0.3 μg/mL.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user.

Restrictions: For Research Use only

Stockage

Concentration: 0,5 mg/mL

Buffer: Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Conseil sur la manipulation: Avoid repeated freezing and thawing.

Stock: 4 °C/-20 °C

Stockage commentaire: Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.

Détails sur CNR1

Antigène: CNR1 (Cannabinoid Receptor 1 (CNR1))

Autre désignation: Cannabinoid Receptor 1

Sujet: Cannabinoid Receptor 1 is one of two main cannabinoid receptors which are G-protein-coupled receptors inhibiting adenylate cyclase activity. The CB(1) receptor is densely distributed in areas of the brain related to motor control, cognition, emotional responses, motivated behaviour and homeostasis. Cannabinoid receptors have a complex molecular architecture that allows a single receptor to recognize multiple classes of compounds and produce an array of distinct downstream effects. Recent pharmacological advances have led to the synthesis of cannabinoid receptor agonists and antagonists. This has helped in the development of new strategies for the treatment of pain, obesity, neurological diseases including multiple sclerosis, emotional disturbances such as anxiety and other psychiatric disorders including drug and alcohol addiction.Synonyms: CANN6, CB-R, CB1, CNR, CNR1

ID gène: 1268, 9606

UniProt: P21554

Pathways: Feeding Behaviour